{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:03:36Z","timestamp":1779836616238,"version":"3.53.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82260566"],"award-info":[{"award-number":["82260566"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-46935-7","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T13:34:11Z","timestamp":1775309651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["DTX3L promotes ovarian cancer progression and cisplatin resistance by activating JAK1\/STAT1\/OAS3 pathway"],"prefix":"10.1038","volume":"16","author":[{"given":"Fangfang","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shien","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,4]]},"reference":[{"issue":"4","key":"46935_CR1","first-page":"284","volume":"68","author":"LA Torre","year":"2018","unstructured":"Torre, L. A. et al. Ovarian cancer statistics, 2018. CA Cancer J. Clin. 68(4), 284\u2013296 (2018).","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"46935_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.5732\/cjc.014.10273","volume":"34","author":"M Devouassoux-Shisheboran","year":"2015","unstructured":"Devouassoux-Shisheboran, M. & Genestie, C. Pathobiology of ovarian carcinomas. Chin. J. Cancer. 34 (1), 50\u201355 (2015).","journal-title":"Chin. J. Cancer"},{"issue":"3","key":"46935_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/IGC.0b013e31823c6f80","volume":"22","author":"JD Seidman","year":"2012","unstructured":"Seidman, J. D., Yemelyanova, A., Cosin, J. A., Smith, A. & Kurman, R. J. Survival rates for international federation of gynecology and obstetrics stage III ovarian carcinoma by cell type: A study of 262 unselected patients with uniform pathologic review. Int. J. Gynecol. Cancer 22(3), 367\u201371 (2012).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"46935_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev-biochem-060815-014922","volume":"86","author":"N Zheng","year":"2017","unstructured":"Zheng, N. & Shabek, N. Ubiquitin ligases: Structure, function, and regulation. Annu. Rev. Biochem. 86, 129\u2013157 (2017).","journal-title":"Annu. Rev. Biochem."},{"issue":"1","key":"46935_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/cells13010029","volume":"13","author":"D Spano","year":"2023","unstructured":"Spano, D. & Catara, G. Targeting the ubiquitin-proteasome system and recent advances in cancer therapy. Cells 13(1), 29 (2023).","journal-title":"Cells"},{"key":"46935_CR6","doi-asserted-by":"publisher","first-page":"e76100","DOI":"10.7554\/eLife.76100","volume":"11","author":"J Du","year":"2022","unstructured":"Du, J. et al. A cryptic K48 ubiquitin chain binding site on UCH37 is required for its role in proteasomal degradation. Elife 11, e76100 (2022).","journal-title":"Elife"},{"issue":"3","key":"46935_CR7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1083\/jcb.200810114","volume":"185","author":"E Lauwers","year":"2009","unstructured":"Lauwers, E., Jacob, C. & Andr\u00e9, B. K63-linked ubiquitin chains as a specific signal for protein sorting into the multivesicular body pathway. J. Cell. Biol. 185 (3), 493\u2013502 (2009).","journal-title":"J. Cell. Biol."},{"issue":"12","key":"46935_CR8","volume":"11","author":"L Zhao","year":"2024","unstructured":"Zhao, L. et al. TRAF4-mediated LAMTOR1 ubiquitination promotes mTORC1 activation and inhibits the inflammation-induced colorectal cancer progression. Adv. Sci. (Weinh.) 11(12), e2301164 (2024).","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"6","key":"46935_CR9","doi-asserted-by":"publisher","first-page":"623","DOI":"10.4161\/cbt.2.6.677","volume":"2","author":"Y Sun","year":"2003","unstructured":"Sun, Y. Targeting E3 ubiquitin ligases for cancer therapy. Cancer Biol Ther 2(6), 623\u20139 (2003).","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"46935_CR10","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1042\/BST20220501","volume":"50","author":"Carlos Vela-Rodr\u00edguez","year":"2022","unstructured":"Carlos Vela-Rodr\u00edguez. Activities and binding partners of E3 ubiquitin ligase DTX3L and its roles in cancer.. Biochem. Soc. Trans. 50 (6), 1683\u20131692 (2022).","journal-title":"Biochem. Soc. Trans."},{"key":"46935_CR11","first-page":"9706997","volume":"25","author":"Lidong Wang","year":"2021","unstructured":"Wang, Lidong. Functions and Molecular Mechanisms of Deltex Family Ubiquitin E3 Ligases in Development and Disease. Front. Cell. Dev. Biol. 25, 9706997 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"issue":"4","key":"46935_CR12","first-page":"17","volume":"26","author":"Y Qingsheng","year":"2023","unstructured":"Qingsheng, Y. & Ding, J. Khan,et al.DTX3L E3 ligase targets p53 for degradation at poly ADP-ribose polymerase-associated DNA damage.sitesiScience. Iscience 26(4), 17 (2023).","journal-title":"Iscience"},{"key":"46935_CR13","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/ni.3279","volume":"16","author":"Y Zhang","year":"2015","unstructured":"Zhang, Y. et al. PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection. Nat. Immunol. 16, 1215\u20131227 (2015).","journal-title":"Nat. Immunol."},{"key":"46935_CR14","first-page":"7e31334","volume":"19","author":"Y Pang-Kuo Lo","year":"2018","unstructured":"Pang-Kuo Lo, Y. et al. LIPG signaling promotes tumor initiation and metastasis of human basal-like triplenegative breast cancer. Elife 19, 7e31334 (2018).","journal-title":"Elife"},{"issue":"1","key":"46935_CR15","first-page":"861","volume":"3","author":"H Wei","year":"2023","unstructured":"Wei, H. et al. Silencing DTX3L Inhibits the Progression of Cervical Carcinoma by Regulating PI3K\/AKT\/mTOR Signaling Pathway. Int. J. Mol. Sci(. 3 (1), 861 (2023).","journal-title":"Int. J. Mol. Sci("},{"issue":"2","key":"46935_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-023-10451-4","volume":"62","author":"L Chen","year":"2023","unstructured":"Chen, L. et al. DTX3L Accelerates Pancreatic cancer Progression via FAK\/PI3K\/AKT Axis. Biochem Genet 17. https:\/\/doi.org\/10.1007\/s10528-023-10451-4 (2023).","journal-title":"Biochem Genet"},{"issue":"2","key":"46935_CR17","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3892\/ijmm.2017.3023","volume":"40","author":"P Xu","year":"2017","unstructured":"Xu, P. et al. DTX3L is upregulated in glioma and is associated with glioma progression. Int. J. Mol. Med. 40 (2), 491\u2013498 (2017).","journal-title":"Int. J. Mol. Med."},{"key":"46935_CR18","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.18632\/oncotarget.3120","volume":"6","author":"DP Johnson","year":"2015","unstructured":"Johnson, D. P. et al. HDAC1,2 inhibition impairs EZH2- and BBAP-mediated DNA repair to overcome chemoresistance in EZH2 gain-of-function mutant diffuse large B-cell lymphoma. Oncotarget 6, 4863\u20134887 (2015).","journal-title":"Oncotarget"},{"key":"46935_CR19","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317703941","volume":"39","author":"Y Shen","year":"2017","unstructured":"Shen, Y. et al. Effects of DTX3L on the cell proliferation, adhesion, and drug resistance of multiple myeloma cells. Tumour Biol 39, 1010428317703941 (2017).","journal-title":"Tumour Biol"},{"key":"46935_CR20","doi-asserted-by":"publisher","first-page":"14290","DOI":"10.18632\/oncotarget.3742","volume":"6","author":"ND Thang","year":"2015","unstructured":"Thang, N. D. et al. Deltex-3-like (DTX3L) stimulates metastasis of melanoma through FAK\/PI3K\/AKT but not MEK\/ERK pathway. Oncotarget 6, 14290\u201314299 (2015).","journal-title":"Oncotarget"},{"key":"46935_CR21","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3892\/mmr.2016.5976","volume":"15","author":"ND Thang","year":"2017","unstructured":"Thang, N. D., Minh, N. V. & Huong, P. T. Translocation of BBAP from the cytoplasm to the nucleus reduces the metastatic ability of vemurafenib-resistant SKMEL28 cells. Mol. Med. Rep. 15, 317\u2013322 (2017).","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"46935_CR22","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1038\/emm.2014.110","volume":"47","author":"UY Choi","year":"2015","unstructured":"Choi, U. Y., Kang, J. S., Hwang, Y. S. & Kim, Y. J. Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases. Exp. Mol. Med. 47 (3), e144 (2015).","journal-title":"Exp. Mol. Med."},{"issue":"12","key":"46935_CR23","doi-asserted-by":"publisher","first-page":"8035","DOI":"10.4049\/jimmunol.0902728","volume":"183","author":"RJ Lin","year":"2009","unstructured":"Lin, R. J. et al. Distinct antiviral roles for human 2\u2019,5\u2019-oligoadenylate synthetase family members against dengue virus infection. J. Immunol. 183(12), 8035\u201343 (2009).","journal-title":"J. Immunol."},{"issue":"1","key":"46935_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12862-018-1315-x","volume":"18","author":"J Hu","year":"2018","unstructured":"Hu, J. et al. Origin and development of oligoadenylate synthetase immune system. BMC Evol. Biol. 18 (1), 201 (2018).","journal-title":"BMC Evol. Biol."},{"issue":"4","key":"46935_CR25","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1139\/bcb-2023-0369","volume":"102","author":"A Koul","year":"2024","unstructured":"Koul, A., Hui, L. T., Lubna, N. & McKenna, S. A. Distinct domain organization and diversity of 2\u2019-5\u2019-oligoadenylate synthetases. Biochem. Cell. Biol. 102 (4), 305\u2013318 (2024).","journal-title":"Biochem. Cell. Biol."},{"issue":"5","key":"46935_CR26","doi-asserted-by":"publisher","first-page":"e9292","DOI":"10.1590\/1414-431x20209292","volume":"53","author":"F Gao","year":"2020","unstructured":"Gao, F., Tan, Y. & Luo, H. MALAT1 is involved in type I IFNs-mediated systemic lupus erythematosus by up-regulating OAS2, OAS3, and OASL. Braz J. Med. Biol. Res. 53 (5), e9292 (2020).","journal-title":"Braz J. Med. Biol. Res."},{"issue":"1","key":"46935_CR27","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1186\/s12885-022-10102-8","volume":"22","author":"L Gao","year":"2022","unstructured":"Gao, L. et al. Values of OAS gene family in the expression signature, immune cell infiltration and prognosis of human bladder cancer. BMC Cancer. 22 (1), 1016 (2022).","journal-title":"BMC Cancer"},{"issue":"1","key":"46935_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00262-024-03898-w","volume":"74","author":"S Zhang","year":"2024","unstructured":"Zhang, S. et al. Targeting OAS3 for reversing M2d infiltration and restoring anti-tumor immunity in pancreatic cancer. Cancer Immunol. Immunother. 74(1), 37 (2024).","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"46935_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s41065-024-00353-9","volume":"161","author":"J Lu","year":"2024","unstructured":"Lu, J., Yang, L., Yang, X., Chen, B. & Liu, Z. Investigating the clinical significance of OAS family genes in breast cancer: An in vitro and in silico study. Hereditas 161(1), 50 (2024).","journal-title":"Hereditas"},{"issue":"1","key":"46935_CR30","doi-asserted-by":"publisher","first-page":"10596","DOI":"10.1038\/s41467-024-54978-5","volume":"15","author":"Q Ye","year":"2024","unstructured":"Ye, Q. et al. DTX3L-mediated TIRR nuclear export and degradation regulates DNA repair pathway choice and PARP inhibitor sensitivity. Nat. Commun. 15 (1), 10596 (2024).","journal-title":"Nat. Commun."},{"issue":"1","key":"46935_CR31","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13073-024-01422-4","volume":"16","author":"R Li","year":"2024","unstructured":"Li, R. et al. Spatial transcriptome profiling identifies DTX3L and BST2 as key biomarkers in esophageal squamous cell carcinoma tumorigenesis. Genome Med. 16 (1), 148 (2024).","journal-title":"Genome Med."},{"issue":"4","key":"46935_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2023.168434","volume":"436","author":"H Saleh","year":"2024","unstructured":"Saleh, H., Liloglou, T., Rigden, D. J., Parsons, J. L. & Grundy, G. J. KH-like domains in PARP9\/DTX3L and PARP14 coordinate protein-protein interactions to promote cancer cell survival. J. Mol. Biol. 436(4), 168434. https:\/\/doi.org\/10.1016\/j.jmb.2023.168434 (2024).","journal-title":"J. Mol. Biol."},{"key":"46935_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-125","volume":"13","author":"SB Bachmann","year":"2014","unstructured":"Bachmann, S. B. et al. DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells. Mol. Cancer 13, 125. https:\/\/doi.org\/10.1186\/1476-4598-13-125 (2014).","journal-title":"Mol. Cancer"},{"issue":"6","key":"46935_CR34","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1042\/BST20220501","volume":"50","author":"C Vela-Rodr\u00edguez","year":"2022","unstructured":"Vela-Rodr\u00edguez, C. & Lehti\u00f6, L. Activities and binding partners of E3 ubiquitin ligase DTX3L and its roles in cancer. Biochem. Soc. Trans. 50 (6), 1683\u20131692 (2022).","journal-title":"Biochem. Soc. Trans."},{"issue":"13","key":"46935_CR35","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.3390\/cells12131680","volume":"12","author":"P Scalia","year":"2023","unstructured":"Scalia, P., Williams, S. J., Suma, A. & Carnevale, V. The DTX protein family: An emerging set of E3 ubiquitin ligases in cancer. Cells 12(13), 1680 (2023).","journal-title":"Cells"},{"issue":"1","key":"46935_CR36","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","volume":"8","author":"C Xue","year":"2023","unstructured":"Xue, C. et al. Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer. Signal. Transduct. Target. Ther. 8 (1), 204 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"15","key":"46935_CR37","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1111\/febs.16780","volume":"290","author":"KC Lockwood","year":"2023","unstructured":"Lockwood, K. C. et al. KIAA0317 regulates SOCS1 stability to ameliorate colonic inflammation. FEBS J. 290(15), 3802\u20133811 (2023).","journal-title":"FEBS J."},{"issue":"9","key":"46935_CR38","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1002\/hed.27803","volume":"46","author":"HO Caglar","year":"2024","unstructured":"Caglar, H. O. et al. Bioinformatics approach combined with experimental verification reveals OAS3 gene implicated in paclitaxel resistance in head and neck cancer. Head Neck 46(9), 2178\u20132196 (2024).","journal-title":"Head Neck"},{"issue":"5","key":"46935_CR39","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.virs.2022.07.013","volume":"37","author":"B Zheng","year":"2022","unstructured":"Zheng, B., Zhou, X., Tian, L., Wang, J. & Zhang, W. IFN-\u03b21b induces OAS3 to inhibit EV71 via IFN-\u03b21b\/JAK\/STAT1 pathway. Virol. Sin. 37(5), 676\u2013684. https:\/\/doi.org\/10.1016\/j.virs.2022.07.013 (2022).","journal-title":"Virol. Sin."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46935-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46935-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46935-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T22:25:45Z","timestamp":1779834345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46935-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,4]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46935"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46935-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,4]]},"assertion":[{"value":"15 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol has been reviewed and approved by the Ethical Review Committee of the First Affiliated Hospital of Guangxi Medical University(Ethics Approval Number:202508005). Animal experiments were conducted in strict accordance with the guidelines approved by the Animal Care and Welfare Committee of Guangxi Medical University. The tumor burden in nude mice in this study did not exceed the recommended size, and the laboratory animals were anesthetized and euthanized using acceptable methods.Our study was reported in accordance with the ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients who participated in this study have consented to the public publication of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Patient consent for publication"}}],"article-number":"16318"}}